Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: Real-world data analysis

References

• Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology. 2016;123(3):655–662. doi:10.1016/j.ophtha.2015.10.028.
   PubMed Web of Science ®Google Scholar
• National Eye Institute. Facts About Uveitis. https://nei.nih.gov/health/uveitis/uveitis.2011. Accessed June 7th, 2017.
   Google Scholar
• Jabs DA. Epidemiology of uveitis. Ophthalmic Epidemiol. 2008;15(5):283–284. doi:10.1080/09286580802478724.
   PubMed Web of Science ®Google Scholar
• Uchiyama E, Papaliodis GN, Lobo AM, Sobrin L. Side-effects of anti-inflammatory therapy in uveitis. Semin Ophthalmol. 2014;29(5–6):456–467. doi:10.3109/08820538.2014.959203.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Immunosuppression for the uveitides. Opthalmology. 2018;125(2):193-202. doi:10.1016/j.ophtha.2017.08.007.
   Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513.
   PubMed Web of Science ®Google Scholar
• Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469–474. doi:10.4158/EP08331.RAR.
   PubMed Web of Science ®Google Scholar
• Stanbury R, Graham E. Systemic corticosteroid therapy—side effects and their management. Br J Ophthalmol. 1998;82:704–708.
   PubMed Web of Science ®Google Scholar
• American Optometric Association. Optometric clinical practice guideline: care of the patient with anterior uveitis. https://www.aoa.org/documents/optometrists/CPG-7.pdf.1994.
   Google Scholar
• Jh K, Mm A, Jt H, Ea S, Je T, Da J. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. JAMA. 2017;317(19):1993–2005. doi:10.1001/jama.2017.5103.
   PubMed Web of Science ®Google Scholar
• Jea SY, Byon IS, Oum BS. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis. Korean J Ophthalmol. 2006;20(2):99–103. doi:10.3341/kjo.2006.20.2.99.
   PubMedGoogle Scholar
• Nozik RA. Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:695–705.
   PubMedGoogle Scholar
• Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1995;39:71–76.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Hatef E, Kayen B, et al. A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology. 2011;118(1):184–190. doi:10.1016/j.ophtha.2010.03.029.
   PubMed Web of Science ®Google Scholar
• Joffe MM, Pistilli M, Kempen JH. Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiol. 2013;20(4):197–200. doi:10.3109/09286586.2013.792939.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Skup M, Tundia N, et al. Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis. Acta Ophthalmol. 2016;94(5):e331–339. doi:10.1111/aos.12987.
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MA, Nallamothu BK. Authors’ reply to Hamilton. Bmj. 2017;357:j2538.
   PubMedGoogle Scholar
• Gauthier G, Guerin A, Zhdanava M, et al. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis. BMC Psychiatry. 2017;17(1):222. doi:10.1186/s12888-017-1489-6.
   PubMedGoogle Scholar
• Dalal AA, Duh MS, Gozalo L, et al. Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma. J Manag Care Spec Pharm. 2016;22(7):833–847. doi:10.18553/jmcp.2016.22.7.833.
   PubMedGoogle Scholar
• Avina-Zubieta JA, Abrahamowicz M, De Vera MA, et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford). 2013;52(1):68–75. doi:10.1093/rheumatology/kes353.
   PubMed Web of Science ®Google Scholar
• Imai K, Ratkovic M. Covariate balancing propensity score. J R Stat Soc Series B Stat Methodol. 2014;76(1):243–263. doi:10.1111/rssb.12027.
   Web of Science ®Google Scholar
• Yang S, Eaton CB, Lu J, Lapane KL. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review. Pharmacoepidemiol Drug Saf. 2014;23(6):560–571. doi:10.1002/pds.3569.
   PubMed Web of Science ®Google Scholar
• Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156. doi:10.1093/aje/kwj149.
   PubMed Web of Science ®Google Scholar
• Jin H, Tu D, Zhao N, Shepherd LE, Goss PE. Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover. J Clin Oncol. 2012;30(7):718–721. doi:10.1200/JCO.2010.34.4010.
   PubMed Web of Science ®Google Scholar
• Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. doi:10.1186/1751-0473-3-17.
   PubMedGoogle Scholar
• Sagara I, Giorgi R, Doumbo OK, Piarroux R, Gaudart J. Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data. Malar J. 2014;13:293. doi:10.1186/1475-2875-13-293.
   PubMed Web of Science ®Google Scholar
• Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57(2):131–141. doi:10.1016/S0895-4356(03)00246-4.
   PubMed Web of Science ®Google Scholar
• Suhler EB, Thorne JE, Mittal M, et al. Corticosteroidrelatedadverse events systematically increase with corticosteroid dose in noninfectious intermediate, posterior,or panuveitis: post hoc analyses from the VISUAL1 and VISUAL-2 trials. Ophthalmology. 2017;124(12):1799-1807. doi:10.1016/j.ophtha.2017.06.017.
   Google Scholar
• Kempen JH, Altaweel MM, Holbrook JT, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118(10):1916–1926. doi:10.1016/j.ophtha.2011.07.027.
   PubMed Web of Science ®Google Scholar
• Broder MS, Sarsour K, Chang E, et al. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis. Semin Arthritis Rheum. 2016;46(2):246–252. doi:10.1016/j.semarthrit.2016.05.009.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116. e117. doi:10.1016/j.jaci.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Del Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all‐cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(2):264–272. doi:10.1002/art.38210.
   PubMed Web of Science ®Google Scholar
• Spivey CA, Griffith J, Kaplan C, et al. Analysis of corticosteroid utilization before initiation of biologic DMARDS among patients with rheumatoid arthritis in the United States. Rheumatol Ther. 2018;5(1):255–270. doi:10.1007/s40744-017-0089-8.
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415.
   PubMed Web of Science ®Google Scholar
• Rowland K. Short-term use of oral corticosteroids was linked to increased risk for sepsis, VTE, and fractures. Ann Intern Med. 2017;167(4):JC20–JC20. doi:10.7326/ACPJC-2017-167-4-020.
   PubMed Web of Science ®Google Scholar
• Hamilton FW. Conclusions of study of short term use of oral corticosteroids and related harms seem wrongheaded. BMJ. 2017;357:j2514.
   PubMedGoogle Scholar